Especially when they have a monoclonal antibody that can go after HIV, cancer, Multiple Scleroris, GvHD, other autoimmune diseases. What big pharma wouldn't want a safe version of a monoclonal antibody that could target all these diseases?
CEO even mentioned that Pfizer is working on a CCR5 drug in cancer of its own I believe, but I think he stated they have more toxicity on their version. I will have to go back and listen. But that's what I thought I heard.